These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

433 related items for PubMed ID: 10481869

  • 1. [Acute and chronic renal failure in patients with myeloma].
    Biriukova LS, Volodiaeva EB, Fetisova EV, Pivnik AV, Margolin OV.
    Ter Arkh; 1999; 71(7):58-64. PubMed ID: 10481869
    [Abstract] [Full Text] [Related]

  • 2. Multiple myeloma--presenting as acute kidney injury.
    Prakash J, Niwas SS, Parekh A, Vohra R, Wani IA, Sharma N, Usha.
    J Assoc Physicians India; 2009 Jan; 57():23-6. PubMed ID: 19753754
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. [Successful haemodialysis treatment of acute renal failure in a patient with multiple myeloma (author's transl)].
    Kopsa H, Schmidt P, Zazgornik J, Balcke P, Deutsch E.
    Med Klin; 1978 May 05; 73(18):668-70. PubMed ID: 651757
    [Abstract] [Full Text] [Related]

  • 5. Treatment of renal failure associated with multiple myeloma. Plasmapheresis, hemodialysis, and chemotherapy.
    Johnson WJ, Kyle RA, Pineda AA, O'Brien PC, Holley KE.
    Arch Intern Med; 1990 Apr 05; 150(4):863-9. PubMed ID: 2183734
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Chronic dialysis in patients with multiple myeloma and renal failure: a worthwhile treatment.
    Iggo N, Palmer AB, Severn A, Trafford JA, Mufti GJ, Taube D, Parsons V.
    Q J Med; 1989 Oct 05; 73(270):903-10. PubMed ID: 2629022
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Melphalan-prednisone versus alternating combination VAD/MP or VND/MP as primary therapy for multiple myeloma: final analysis of a randomized clinical study.
    Cavo M, Benni M, Ronconi S, Fiacchini M, Gozzetti A, Zamagni E, Cellini C, Tosi P, Baccarani M, Tura S, Writing Committee of the "Bologna 90" Clinical Trial.
    Haematologica; 2002 Sep 05; 87(9):934-42. PubMed ID: 12217805
    [Abstract] [Full Text] [Related]

  • 11. [Combination chemotherapy (modified M-2 protocol) for multiple myeloma].
    Iwata Y, Karitani Y, Tanaka I, Kobayashi T, Ohno T, Kageyama S, Katayama N, Kataoka Y, Kamio N, Ohota C.
    Rinsho Ketsueki; 1984 Sep 05; 25(9):1380-7. PubMed ID: 6549187
    [No Abstract] [Full Text] [Related]

  • 12. Cyclophosphamide plus dexamethasone is an efficient initial treatment before high-dose melphalan and autologous stem cell transplantation in patients with newly diagnosed multiple myeloma: results of a randomized comparison with vincristine, doxorubicin, and dexamethasone.
    Mellqvist UH, Lenhoff S, Johnsen HE, Hjorth M, Holmberg E, Juliusson G, Tangen JM, Westin J, Nordic Myeloma Study Group.
    Cancer; 2008 Jan 01; 112(1):129-35. PubMed ID: 17973267
    [Abstract] [Full Text] [Related]

  • 13. [Survival of myeloma patients treated with dialysis].
    Martín Reyes G, Valera A, Frutos MA, Ramos B, Ordóñez V, López de Novales E.
    Nefrologia; 2003 Jan 01; 23(2):131-6. PubMed ID: 12778877
    [Abstract] [Full Text] [Related]

  • 14. [Therapy of multiple myeloma and its complications].
    Avvisati G, Pulsoni A, Petrucci MT, Tribalto M.
    Recenti Prog Med; 1990 Oct 01; 81(10):642-50. PubMed ID: 2291008
    [Abstract] [Full Text] [Related]

  • 15. [Preliminary report of fludarabine, mitoxantrone and dexamethasone in treating refractory or relapsed multiple myeloma].
    Luo SK, Li J, Hong WD, Zhao Y, Tong XZ.
    Ai Zheng; 2005 Dec 01; 24(12):1518-21. PubMed ID: 16351805
    [Abstract] [Full Text] [Related]

  • 16. Toxicity in standard melphalan-prednisone therapy among myeloma patients with renal failure--a retrospective analysis and recommendations for dose adjustment.
    Carlson K, Hjorth M, Knudsen LM, Nordic Myeloma Study Group.
    Br J Haematol; 2005 Mar 01; 128(5):631-5. PubMed ID: 15725084
    [Abstract] [Full Text] [Related]

  • 17. Thalidomide alone or in combination with dexamethasone in patients with advanced, relapsed or refractory multiple myeloma and renal failure.
    Tosi P, Zamagni E, Cellini C, Cangini D, Tacchetti P, Tura S, Baccarani M, Cavo M.
    Eur J Haematol; 2004 Aug 01; 73(2):98-103. PubMed ID: 15245508
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. [Withdrawal of maintenance dialysis in a patient with diagnosed multiple myeloma and renal failure as a consequence of effective anti-tumor treatment].
    Rosa J, Sydor A, Jurczyszyn A, Zabawa-Hołyś S, Nowak J, Czapkowicz-Gryszkiewicz L, Sułowicz W.
    Przegl Lek; 2010 Aug 01; 67(7):547-50. PubMed ID: 21387773
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 22.